Screening after hematopoietic cell transplant
| Cardiovascular risk-factor assessment |
| Immune system If on chronic graft-vs-host disease prevention: gram-positive encapsulated organism prophylaxis, Pneumocystis carinii pneumonia prophylaxis, cytomegalovirus testing Revaccinate after stem cell transplant, yearly inactivated influenza vaccine |
| Ocular clinical symptom evaluation, ocular fundus examination if previously abnormal |
| Dental assessment |
| Pulmonary Clinical pulmonary assessment Smoking avoidance counseling Pulmonary function testing if previously abnormal Chest radiography if previously abnormal |
| Liver Liver enzyme testing if previously abnormal Serum ferritin testing if previously abnormal |
| Kidney Blood pressure screening Urine protein screening Blood urea nitrogen and creatinine testing |
| Muscle and connective tissue Evaluate for muscle weakness if on chronic graft-vs-host disease prevention Physical activity counseling and routine exercise |
| Bone and spine Bone density testing (adult women, all allogeneic transplant recipients and patients at high risk for bone loss), reassess if previously abnormal |
| Nervous system Clinical neurologic evaluation Evaluate for cognitive development |
| Endocrine system Thyroid function testing Growth velocity in children Gonadal function assessment in prepubertal children and in adults if previously abnormal |
| Skin self-examination and sun exposure counseling |
| Gynecologic examination |
| Secondary cancers Vigilance counseling and screening |
| Psychosocial, financial, and quality-of-life clinical assessment, sexual function assessment |
Based on information in references 30 and 32